DOGGY BONE

Brand Owner Address Description
DOGGYBONE Touchlight IP Limited 40 Queen Anne Street London W1G9EL United Kingdom DOGGY BONE;Scientific and technological services, namely, research and design in the field of scientific DNA research and development; chemical and biological analysis and research services; Scientific research into DNA; Scientific research and development into the creation of DNA extracts and constructs; Scientific research, analysis, design and development relating to DNA based drugs and therapies; Scientific research and development in the fields of gene therapy, diagnostics, agribiotechnology and nanotechnology; consultancy relating to DNA research for scientific purposes;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. An agent for treatment of metabolic bone disease, which contains EPO as an active ingredient, or a method for treating a patient with metabolic bone disease, which comprises EPO, is provided. Pharmaceutical products containing EPO as the active ingredient are novel prophylactic and therapeutic agents which show an ameliorative action by healing bone and bone marrow lesions in bone disease, especially bone disease based on impaired bone metabolism, aside from the previously reported erythrocyte increasing action of EPO. Pathological states, targeted by these pharmaceutical products, are bone diseases showing metabolic bone disorders, including renal failure-associated osteodystrophy, marble bone disease, diabetic nephropathy, and osteoporosis.